OptiBiotix Health Plc (LON:OPTI – Get Free Report) dropped 2% on Monday . The company traded as low as GBX 5.50 and last traded at GBX 5.50. 2,352 shares were traded during trading, a decline of 99% from the average session volume of 388,060 shares. The stock had previously closed at GBX 5.61.
OptiBiotix Health Stock Performance
The business has a 50-day moving average of GBX 6.04 and a 200-day moving average of GBX 6.01. The stock has a market capitalization of £5.68 million, a price-to-earnings ratio of -1.43 and a beta of 1.85.
OptiBiotix Health (LON:OPTI – Get Free Report) last issued its quarterly earnings data on Thursday, May 28th. The company reported GBX (3.84) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative net margin of 333.62% and a negative return on equity of 52.92%. The company had revenue of GBX 117 million during the quarter.
Insider Activity
About OptiBiotix Health
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Featured Stories
- Five stocks we like better than OptiBiotix Health
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
